EXAMINING THE LIMITS OF THE BUPRENORPHINE INTERDOSING INTERVAL: DAILY, EVERY-THIRD-DAY AND EVERY-FIFTH-DAY DOSING REGIMENS.
Es más probable que los pacientes ambulatorios dependientes de opiáceos acudan a tratamiento farmacológico si se puede establecer una pauta de dosificación con interválos mayores de un día. Estos estudios compararon los síntomas de abstinencia durante pautas de dosificación de buprenorfina de 24-, 7...
Gardado en:
| Autor Principal: | |
|---|---|
| Outros autores: | |
| Formato: | Libro |
| Idioma: | Lingua castelá inglés |
| Subjects: | |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares: EXAMINING THE LIMITS OF THE BUPRENORPHINE INTERDOSING INTERVAL: DAILY, EVERY-THIRD-DAY AND EVERY-FIFTH-DAY DOSING REGIMENS.
- EFFICACY OF DAILY AND ALTERNATE-DAY DOSING REGIMENS WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET
- A COMPARISON OF FOUR BUPRENORPHINE DOSING REGIMENS USING OPEN-DOSING PROCEDURES: IS TWICE-WEEKLY DOSING POSSIBLE?
- BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE: THE RELATIVE EFFICACY OF DAILY, TWICE AND THRICE WEEKLY DOSING
- BUPRENORPHINE DOSING REGIME FOR INPATIENT HEROIN WITHDRAWAL: A SYMPTOM-TRIGGERED DOSE TITRATION STUDY
- PRELIMINARY ASSESSMENT OF A 10-DAY RAPID DETOXIFICATION PROGRAMME USING HIGH DOSAGE BUPRENORPHINE
- ‘I know it was every week, but I can't be sure if it was every day’: Domestic violence and women with learning disabilities